PMS supports Guidant's heart failure device
This article was originally published in Clinica
Executive Summary
A European post-market (PMS) surveillance study of Guidant's cardiac resynchronisation devices for treating heart failure reveals that patients receiving the products experience a "marked improvement" in their condition, the company has reported.